Association between complement regulatory protein factor H and AM34 antigen, detected in senile plaques

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 55, Issue 5, 2000, Pages

  Honda, Saho ^b   Itoh, Fumio ^a   Yoshimoto, Mitsuru ^b   Ohno, Satoko ^b   Hinoda, Yuji ^b   Imai, Kohzoh ^b  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT FACTOR H; COMPLEMENTARY DNA; DNA FRAGMENT; MESSENGER RNA;

ALZHEIMER DISEASE; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOPRECIPITATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENILE PLAQUE; WESTERN BLOTTING;

EID: 0034064884     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/55.5.M265     Document Type: Article

References (26)

1. Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA. 1985;82:4245-4249.
2. Glenner GG. Wong CW. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun. 1984;120:885-890.
3. Kang J, Lemaire HG, Unterbeck A, et al. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature. 1987;325:733-736.
4. Jarrett JT, Berger EP, Lansbury PT Jr. The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry. 1993;32:4693-4697.
5. Scheuner D, Eckman C, Jensen M, et al. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat Med. 1996;2:864-870.
6. Eikelenboom P, Stam FC. Immunoglobulins and complement factors in senile plaques. An immunoperoxidase study. Acta Neuropathol (Berl). 1982;57:239-242.
7. Johnson SA, Lampert-Etchells M, Pasinetti GM, Rozovsky I, Finch CE. Complement mRNA in the mammalian brain: responses to Alzheimer's disease and experimental brain lesioning. Neurobiol Aging. 1992;13:641-648.
8. Jiang H, Burdick D, Glabe CG, Cotman CW, Tenner AJ. β-Amyloid activates complement by binding to a specific region of the collagen-like domain of the Clq A chain. J Immunol. 1994;152:5050-5059.
9. Watson MD, Roher AE, Kim KS, Spiegel K, Emmerling MR. Complement interaction with amyloid-β1-42: a nidus for inflammation in AD brains. Amyloid. 1997;4:147-156.
10. Bradt BM, Lolb WP, Cooper NR. Complement-dependent proinflammatory properties of the Alzheimer's disease β-peptide. J Exp Med. 1998;188:431-438.
11. Webster S, Glabe C, Rogers J. Multivalent binding of complement protein Clq to the amyloid β-peptide (Aβ) promotes the nucleation phase of Aβ aggregation. Biochem Biophys Res Commun. 1995;217: 869-875.
12. Ota M, Itoh F, Imai K. Analysis of the epitope of an amyloid-related molecule, AM34 antigen, and its clinical application. Sapporo Med J. 1993;62:175-186.
13. Weiler JM, Daha MR, Austen KF, Fearon DT. Control of the amplification convertase of complement by the plasma protein β1H. Proc Natl Acad Sci USA. 1976;73:3268-3272.
14. Pangburn MK, Schreiber RD, Muller-Eberhard HJ. Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein β1H for cleavage of C3b and C4b in solution. J Exp Med. 1977;146:257-270.
15. Ripoche J, Day AJ, Harris TJ, Sim RB. The complete amino acid sequence of human complement factor H. Biochem J. 1988;249:593-602.
16. Zipfel PF, Skerka C. Complement factor H and related proteins: an expanding family of complement-reaulatory proteins? Immunol Today. 1994;15:121-126.
17. Skerka C, Hellwage J, Weber W, et al. The human factor H-related protein 4 (FHR-4). A novel short consensus repeat-containing protein is associated with human triglyceride-rich lipoproteins. J Biol Chem. 1997;272:5627-5634.
18. Gordon DL, Kaufman RM, Blackmore TK, Kwong J, Lublin DM. Identification of complement regulatory domains in human factor H. J Immunol. 1995;155:348-356.
19. Saiki RK, Scharf S, Faloona F, et al. Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science. 1985;230:1350-1354.
20. Avery VM, Adrian DL, Gordon DL. Detection of mosaic protein mRNA in human astrocytes. Immunol Cell Biol. 1993;71(pt 3):215-219.
21. Seya T, Nakamura K, Masaki T, Ichihara-Itoh C, Matsumoto M, Nagasawa S. Human factor H and C4b-binding protein serve as factor I-cofactors both encompassing inactivation of C3b and C4b. Mol Immunol. 1995;32:355-360.
22. Ollert MW, David K, Bredehorst R, Vogel CW. Classical complement pathway activation on nucleated cells. Role of factor H in the control of deposited C3b. J Immunol. 1995;155:4955-4962.
23. Ohtsuka H, Imamura T, Matsushita M, et al. Thrombin generates monocyte chemotactic activity from complement factor H. Immunology. 1993;80:140-145.
24. Nabil K, Rihn B, Jaurand MC, et al. Identification of human complement factor H as a chemotactic protein for monocytes. Biochem J. 1997;326:377-383.
25. Liang JS, Sloane JA, Wells JM, Abraham CR, Fine RE, Sipe JD. Evidence for local production of acute phase response apolipoprotein serum amyloid A in Alzheimer's disease brain. Neurosci Lett. 1997; 225:73-76.
26. McGeer PL, Schulder M, McGeer EG. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology. 1996;47:425-432.